CD4 and thyroid gland carcinoma: When thyroid cancers progress in the context of satisfactory suppression of host TSH, we may also ask whether immune checkpoint actions of T4 in the TSH-suppression treatment approach is blocking any immune system activity that might be present and potentially relevant to clinical management.